Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Management of oligometastatic disease in NSCLC

The role of systemic therapy in patients with or without molecular alterations

Date

23 Oct 2023

Session

Management of oligometastatic disease in NSCLC

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Ross Soo

Authors

R.A. Soo

Author affiliations

  • Haematology-oncology Department, NCIS - National University Cancer Institute Singapore, 119074 - Singapore/SG

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

The role of surgery

Presenter: Giulia Veronesi

Session: Management of oligometastatic disease in NSCLC

Resources:

Slides

Webcast

The role of radiation therapy

Presenter: Cécile Le Pechoux

Session: Management of oligometastatic disease in NSCLC

Resources:

Slides

Webcast

Q&A and Discussion

Presenter: All Speakers

Session: Management of oligometastatic disease in NSCLC

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.